CIP2A is a target of bortezomib in human triple negative breast cancer cells (Q36245640)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | CIP2A is a target of bortezomib in human triple negative breast cancer cells |
scientific article |
Statements
1 reference
CIP2A is a target of bortezomib in human triple negative breast cancer cells (English)
1 reference
Ling-Ming Tseng
1 reference
Chun-Yu Liu
1 reference
Kung-Chi Chang
1 reference
Pei-Yi Chu
1 reference
Chung-Wai Shiau
1 reference
Kuen-Feng Chen
1 reference
26 April 2012
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference